Literature DB >> 28085695

Incidence of Occult Intrahepatic Metastasis in Hepatocellular Carcinoma Treated With Transplantation Corresponds to Early Recurrence Rates After Partial Hepatectomy.

David D Aufhauser1, Eran Sadot2,3, Douglas R Murken1, Kevin Eddinger1, Maarouf Hoteit4, Peter L Abt1, David S Goldberg4, Ronald P DeMatteo5, Matthew H Levine1.   

Abstract

OBJECTIVE: This study aimed to compare the incidence of radiologically unrecognized (occult) hepatocellular carcinoma (HCC) lesions in explant hepatectomy specimens from orthotopic liver transplants (OLTs) performed for HCC with rates of HCC intrahepatic recurrence after resection. SUMMARY OF BACKGROUND DATA: Resection of HCC is associated with high rates of intrahepatic HCC recurrence. However, it is unclear whether these recurrences represent incomplete resection of unrecognized metastatic lesions from the primary tumor or subsequent de novo tumor formation due to inherent biological proclivity for HCC formation.
METHODS: We collected patient, tumor, and pathology data on HCC patients treated surgically from 3696 OLTs in the Organ Procurement and Transplantation (OPTN) national database, 299 OLTs at a single transplant center, and 232 partial hepatectomies from a hepatobiliary cancer center.
RESULTS: In the OPTN and high-volume transplant center cohorts, 37% and 42% of patients had occult HCC lesions on explant pathology, respectively. Among cancer center patients, the 2-year recurrence rate was 46%, and 74% of patients who recurred presented with liver only recurrence.
CONCLUSION: Although the transplant and resection populations differ, occult multifocality is common in transplant explants and similar to the 46% early recurrence rate following partial hepatectomy. These data suggest that noncurative resection often results from occult intrahepatic multifocality present at the time of resection rather than a malignant predisposition of the remnant liver with de novo tumorigenesis.

Entities:  

Mesh:

Year:  2018        PMID: 28085695      PMCID: PMC5507755          DOI: 10.1097/SLA.0000000000002135

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  26 in total

1.  Debate: Resection for early hepatocellular carcinoma.

Authors:  Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2008-12-23       Impact factor: 3.452

2.  Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence.

Authors:  Giorgio Ercolani; Gian Luca Grazi; Matteo Ravaioli; Massimo Del Gaudio; Andrea Gardini; Matteo Cescon; Giovanni Varotti; Francesco Cetta; Antonino Cavallari
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

3.  Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.

Authors:  Min-Su Park; Kwang-Woong Lee; Suk-Won Suh; Tae You; Youngrok Choi; Hyeyoung Kim; Geun Hong; Nam-Joon Yi; Choon-Hyuck David Kwon; Jae-Won Joh; Suk-Koo Lee; Kyung-Suk Suh
Journal:  Transplantation       Date:  2014-01-15       Impact factor: 4.939

4.  Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival.

Authors:  F Y Yao; L Ferrell; N M Bass; J J Watson; P Bacchetti; A Venook; N L Ascher; J P Roberts
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

5.  Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis.

Authors:  J Belghiti; Y Panis; O Farges; J P Benhamou; F Fekete
Journal:  Ann Surg       Date:  1991-08       Impact factor: 12.969

6.  Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value.

Authors:  G L Grazi; G Ercolani; F Pierangeli; M Del Gaudio; M Cescon; A Cavallari; A Mazziotti
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

Review 7.  Resection and liver transplantation for hepatocellular carcinoma.

Authors:  Josep M Llovet; Myron Schwartz; Vincenzo Mazzaferro
Journal:  Semin Liver Dis       Date:  2005       Impact factor: 6.115

8.  Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma.

Authors:  K Hanazaki; S Kajikawa; N Shimozawa; M Mihara; K Shimada; M Hiraguri; N Koide; W Adachi; J Amano
Journal:  J Am Coll Surg       Date:  2000-10       Impact factor: 6.113

Review 9.  Is liver transplantation justified for the treatment of HCC in Child's A patients? Not always.

Authors:  Carlos O Esquivel
Journal:  Liver Transpl       Date:  2003-05       Impact factor: 5.799

10.  Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

Authors:  Yujin Hoshida; Augusto Villanueva; Masahiro Kobayashi; Judit Peix; Derek Y Chiang; Amy Camargo; Supriya Gupta; Jamie Moore; Matthew J Wrobel; Jim Lerner; Michael Reich; Jennifer A Chan; Jonathan N Glickman; Kenji Ikeda; Masaji Hashimoto; Goro Watanabe; Maria G Daidone; Sasan Roayaie; Myron Schwartz; Swan Thung; Helga B Salvesen; Stacey Gabriel; Vincenzo Mazzaferro; Jordi Bruix; Scott L Friedman; Hiromitsu Kumada; Josep M Llovet; Todd R Golub
Journal:  N Engl J Med       Date:  2008-10-15       Impact factor: 91.245

View more
  10 in total

1.  Risk Factors and Center-Level Variation in Hepatocellular Carcinoma Under-Staging for Liver Transplantation.

Authors:  Nadim Mahmud; Maarouf A Hoteit; David S Goldberg
Journal:  Liver Transpl       Date:  2020-08       Impact factor: 5.799

2.  LR-3 and LR-4 Lesions Are More Likely to Be Hepatocellular Carcinoma in Transplant Patients with LR-5 or LR-TR Lesions.

Authors:  Tzu-Hao Lee; Nathan Hirshman; Diana M Cardona; Carl L Berg; Kathryn J Fowler; Mustafa R Bashir; James Ronald
Journal:  Dig Dis Sci       Date:  2022-03-07       Impact factor: 3.487

3.  A pure nanoICG-based homogeneous lipiodol formulation: toward precise surgical navigation of primary liver cancer after long-term transcatheter arterial embolization.

Authors:  Yang Zhang; Hongwei Cheng; Hu Chen; Peiyao Xu; En Ren; Yonghe Jiang; Dengfeng Li; Xing Gao; Yating Zheng; Pan He; Huirong Lin; Biaoqi Chen; Gan Lin; Aizheng Chen; Chengchao Chu; Jingsong Mao; Gang Liu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-12-23       Impact factor: 10.057

4.  Occult Hepatocellular Carcinoma Associated With Transjugular Intrahepatic Portosystemic Shunts in Liver Transplant Recipients.

Authors:  Lauren N Krumeich; Jenna Mancinelli; Andy Cucchiara; Kevin Eddinger; David Aufhauser; Drew W Goldberg; Evan S Siegelman; Mark Rosen; K Rajender Reddy; Maarouf Hoteit; Emma E Furth; Kim M Olthoff; Abraham Shaked; Matthew Levine; Peter Abt
Journal:  Liver Transpl       Date:  2021-07-21       Impact factor: 6.112

5.  Urotensin II receptor as a potential biomarker for the prognosis of hepatocellular carcinoma patients.

Authors:  Hongtao Wei; Xiaotong Yu; Xiaowei Xue; Hui Liu; Menglong Wang; Yingying Li; Xuejiang Wang; Huiguo Ding
Journal:  Oncol Lett       Date:  2017-07-08       Impact factor: 2.967

Review 6.  Identifying Clonal Origin of Multifocal Hepatocellular Carcinoma and Its Clinical Implications.

Authors:  Di-Yang Xie; Hong-Kai Fan; Zheng-Gang Ren; Jia Fan; Qiang Gao
Journal:  Clin Transl Gastroenterol       Date:  2019-02       Impact factor: 4.488

7.  Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods.

Authors:  Zhuolin Li; Yao Lin; Bizhen Cheng; Qiaoxin Zhang; Yingmu Cai
Journal:  Front Genet       Date:  2021-03-09       Impact factor: 4.599

8.  Expression of Cancer Testis Antigens in Tumor-Adjacent Normal Liver Is Associated with Post-Resection Recurrence of Hepatocellular Carcinoma.

Authors:  Lisanne Noordam; Zhouhong Ge; Hadiye Özturk; Michail Doukas; Shanta Mancham; Patrick P C Boor; Lucia Campos Carrascosa; Guoying Zhou; Thierry P P van den Bosch; Qiuwei Pan; Jan N M IJzermans; Marco J Bruno; Dave Sprengers; Jaap Kwekkeboom
Journal:  Cancers (Basel)       Date:  2021-05-20       Impact factor: 6.639

9.  Uni-, Bi- or Trifocal Hepatocellular Carcinoma in Western Patients: Recurrence and Survival after Percutaneous Thermal Ablation.

Authors:  Ancelin Preel; Margaux Hermida; Carole Allimant; Eric Assenat; Chloé Guillot; Cecilia Gozzo; Serge Aho-Glele; Georges-Philippe Pageaux; Christophe Cassinotto; Boris Guiu
Journal:  Cancers (Basel)       Date:  2021-05-30       Impact factor: 6.639

10.  Huxie Huaji Ointment Induced Apoptosis of Liver Cancer Cells In Vivo and In Vitro by Activating the Mitochondrial Pathway.

Authors:  Yuan Cai; Qing Du; Tian-Hao Deng; Bing-Bing Shen; Yan-Mei Peng; Pu-Hua Zeng; Song-Ren Yu
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-15       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.